All episodes

In this podcast, Dr. Zoe Apalla from the Aristotle University of Thessaloniki, Thessaloniki, Greece, and Dr. Katya Harfmann from the Nationwide Children’s Hospital, Columbus, OH, USA discuss tools for assessing alopecia areata severity, including the Severity of Alopecia Tool, AA Scale, and AA Severity and Morbidity Index. An interactive digital feature is provided for this article at the following link: https://datahub.pfizer.com/aaseverity.

This podcast is published open access in the American Journal of Clinical Dermatology and is fully citeable. You can access the original published vodcast article through the American Journal of Clinical Dermatology website and by using this link: https://link.springer.com/article/10.1007/s40257-025-00973-5....

This podcast is published open access in Dermatology and Therapy and is fully citeable. You can access the original published podcast article through the Dermatology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s13555-025-01491-2. All conflicts of interest can be found online. This podcast is intended for medical professionals.

Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence,...

Avelumab first-line maintenance is an approved treatment for cisplatin-eligible or -ineligible patients with advanced urothelial carcinoma (UC) who are progression free following first-line platinum-based chemotherapy, based on the results of the JAVELIN Bladder 100 phase 3 trial. In recent years, an increasing number of real-world studies have examined the effectiveness and safety of avelumab first-line maintenance in heterogeneous populations from different countries, expanding the clinical evidence base. In this podcast, Dr. Petros Grivas from the University of Washington, Fred Hutch Cancer Center, Seattle, WA, USA, and Dr. Helen H. Moon from Kaiser Permanente, Riverside, CA, USA, discuss findings from these...

In this podcast, Dr. Brittany M. Szymaniak from the Feinberg School of Medicine at Northwestern University, Chicago, IL, USA, Dr. Alicia K. Morgans from the Dana-Farber Cancer Institute, Boston, MA, USA, and Dr. Neal D. Shore from the Carolina Urologic Research Center, Myrtle Beach, SC, USA, aim to identify obstacles to testing for homologous recombination repair (HRR) gene alterations in patients with prostate cancer that healthcare professionals encounter in day-to-day clinical practice, as well as discuss ways to potentially overcome them. This podcast is published open access in Targeted Oncology and is fully citeable. You can access the original published...

In this podcast, Dr. Danny Nguyen from the City of Hope, Huntington Beach, CA, USA, and Dr. Edgardo S. Santos from the Oncology Institute of Hope and Innovation, Broward County, FL, USA, aim to educate on strategies to mitigate and manage dermatologic adverse events associated with amivantamab + lazertinib. This podcast is published open access in Targeted Oncology and is fully citeable. You can access the original published video podcast/vodcast article through the Targeted Oncology website and by using this link: https://link.springer.com/article/10.1007/s11523-025-01163-3. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons...

·         In this podcast, the authors discuss the current therapeutic landscape of NSCLC with actionable alterations and provide their perspectives on treatment algorithms, and how to optimally sequence therapies for patients with tumors harboring actionable alterations, using patient cases to illustrate key principles. This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: https://link.springer.com/article/10.1007/s12325-025-03195-7. All conflicts of interest can be found online. This podcast is intended for medical professionals. Open Access This podcast is licensed under...

·       In this podcast a patient with sarcoma and a specialist sarcoma nurse discuss the patient’s journey from initial diagnosis through to treatment and recovery. They will also discuss the physiological, emotional and mental impact that sarcoma had, as well as the critical role of the cancer nurse specialist within the treatment plan, alongside a patient support group. Listeners to the podcast will gain a better understanding of the challenges in diagnosing soft-tissue sarcoma, the tools that are already available to assist physicians in diagnosis, and the importance of providing patients with clear information throughout the treatment journey....

A podcast focusing on burnout among physicians that treat patients with multiple sclerosis.  This podcast is published open access in Neurology and Therapy and is fully citeable. You can access the original published podcast article through the Neurology and Therapy website and by using this link: Burnout Among Physicians Treating Patients with Multiple Sclerosis in the United States: A Podcast | Neurology and Therapy. All conflicts of interest can be found online. This podcast is intended for medical professionals.  Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation,...

Shared decision-making is essential to the care of patients with advanced renal carcinoma which can empower patients and help the healthcare team understand the patient’s goals of care.  Identification and management of treatment-related adverse events is key to this. In this podcast, a patient author and two healthcare professionals with real-world experience provide insight into the importance of shared decision-making and its utility in the management of treatment-related adverse events in patients with renal cell carcinoma who are receiving axitinib in combination with an immunotherapy agent. This podcast is published open access in Oncology and Therapy and is fully citeable....

In this podcast, Dr. Marcos de Lima from the Ohio State University, Columbus, OH, USA, and Dr. David I. Marks from the University Hospitals Bristol NHS Trust, Bristol, UK, discuss real-world data obtained from the Center for International Blood and Marrow Transplant Research database to evaluate post-allogeneic hematopoietic stem cell transplantation outcomes in adult patients with acute lymphoblastic leukemia who received inotuzumab ozogamicin. This podcast is published open access in Targeted Oncology and is fully citeable. You can access the original published podcast article through the Targeted Oncology website and by using this link: https://link.springer.com/article/10.1007/s11523-025-01129-5. All conflicts of interest can...